🇺🇸 FDA
Patent

US 10370349

Functionalised benzopyran compounds and use thereof

granted A61PA61P35/00A61P35/04

Quick answer

US patent 10370349 (Functionalised benzopyran compounds and use thereof) held by Kazia Therapeutics Limited expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Kazia Therapeutics Limited
Grant date
Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P35/00, A61P35/04